Myriad Genetics, Inc. (MYGN)
4.54
+0.48
(+11.82%)
USD |
NASDAQ |
Oct 02, 16:00
4.54
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Price : 4.54 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.16 | 4.585 | 4.16 | 4.54 | 2.281M |
| Oct 01, 2026 | 4.28 | 4.31 | 4.055 | 4.06 | 1.658M |
| Sep 30, 2026 | 4.28 | 4.385 | 4.22 | 4.31 | 1.505M |
| Sep 29, 2026 | 4.26 | 4.370 | 4.22 | 4.23 | 1.599M |
| Sep 28, 2026 | 4.11 | 4.335 | 4.08 | 4.24 | 1.181M |
| Sep 25, 2026 | 4.16 | 4.25 | 4.065 | 4.17 | 1.648M |
| Sep 24, 2026 | 4.00 | 4.255 | 3.97 | 4.14 | 1.961M |
| Sep 23, 2026 | 4.02 | 4.225 | 3.97 | 4.01 | 1.658M |
| Sep 22, 2026 | 3.90 | 4.055 | 3.76 | 4.02 | 2.487M |
| Sep 21, 2026 | 3.93 | 4.035 | 3.87 | 4.01 | 1.890M |
| Sep 18, 2026 | 4.15 | 4.17 | 3.86 | 3.89 | 3.510M |
| Sep 17, 2026 | 3.885 | 4.17 | 3.75 | 4.14 | 2.831M |
| Sep 16, 2026 | 3.75 | 4.085 | 3.75 | 3.86 | 2.050M |
| Sep 15, 2026 | 3.795 | 3.98 | 3.695 | 3.88 | 4.680M |
| Sep 14, 2026 | 3.43 | 3.82 | 3.42 | 3.79 | 2.599M |
| Sep 11, 2026 | 3.37 | 3.425 | 3.195 | 3.42 | 2.553M |
| Sep 10, 2026 | 3.14 | 3.365 | 3.06 | 3.36 | 3.940M |
| Sep 09, 2026 | 3.11 | 3.215 | 3.085 | 3.19 | 966999.0 |
| Sep 08, 2026 | 3.18 | 3.215 | 3.105 | 3.18 | 1.195M |
| Sep 04, 2026 | 3.19 | 3.20 | 3.15 | 3.19 | 806165.0 |
| Sep 03, 2026 | 3.25 | 3.32 | 3.16 | 3.23 | 959059.0 |
| Sep 02, 2026 | 3.16 | 3.35 | 3.16 | 3.23 | 1.351M |
| Sep 01, 2026 | 2.95 | 3.215 | 2.92 | 3.18 | 3.034M |
| Aug 31, 2026 | 3.15 | 3.26 | 3.04 | 3.22 | 1.543M |
| Aug 28, 2026 | 3.15 | 3.20 | 3.07 | 3.16 | 1.430M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Natera, Inc. | 410.35 |
| Sera Prognostics, Inc. | 2.09 |
| BioRestorative Therapies, Inc. | 2.14 |
| CareDx, Inc. | 67.15 |
| Exagen, Inc. | 8.17 |
Price Related Metrics
| PS Ratio | 0.5275 |
| Price to Book Value | 1.428 |
| Earnings Yield | -26.40% |
| Market Cap | 434.02M |